Mast cell stabilisers

European Journal of Pharmacology

Volumn 778, Issue , 2016, Pages 158-168

  Zhang, Tao ^a   Finn, Deirdre Frances ^a   Barlow, James William ^b   Walsh, John Jarlath ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Immunoglobulin E (IgE); Mast cells; Stabilisers; Tyrosine kinases

Indexed keywords

AMBROXOL; ARTEMISININ; ARTESUNATE; ATORVASTATIN; AZELASTINE; BUMETANIDE; CERIVASTATIN; CROMOGLYCATE DISODIUM; CYCLOSPORIN A; DASATINIB; EPINASTINE; FLAVONOID; FLUINDOSTATIN; FOSTAMATINIB; FUROSEMIDE; IBRUTINIB; KETOTIFEN; LODOXAMIDE TROMETAMOL; NEDOCROMIL; NIFEDIPINE; NILOTINIB; OLOPATADINE; PLACEBO; ROLIPRAM; STABILIZING AGENT; SUNITINIB; TACROLIMUS; THEOPHYLLINE; UNINDEXED DRUG; VERAPAMIL;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ARTHRITIS; ASTHMA; AUTOIMMUNE ARTHRITIS; AUTOIMMUNE DISEASE; DRUG ACTIVITY; DRUG APPROVAL; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; HUMAN; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; REVIEW; RHEUMATOID ARTHRITIS; ANIMAL; CYTOLOGY; DEGRANULATION; DRUG DEVELOPMENT; DRUG EFFECTS; IMMUNOLOGY; PROCEDURES; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ANIMALS; CELL DEGRANULATION; DRUG DISCOVERY; HUMANS; MAST CELLS; SIGNAL TRANSDUCTION;

EID: 84937054209     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.05.071     Document Type: Article

References (150)

1. M.B. Abelson, and P.J. Gomes Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing Exp. Opin. Drug Metab. Toxicol. 4 2008 453 461
2. M.B. Abelson, and L. Spitalny Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity Am. J. Ophthalmol. 125 1998 797 804
3. R.E.C. Altounyan Inhibition of experimental asthma by a new compound, cromolyn sodium "Intal" Acta Allergol. 22 1967 487 495
4. N.G. Arizmendi-Puga, J.A. Enciso, G. Ortega-Pierres, Z. Zhao, M. Duszyk, M. Ulanova, A.D. Befus, and L. Yéez-Mulia Trichinella spiralis: histamine secretion induced by TSL-1 antigens from unsensitized mast cells Exp. Parasitol. 114 2006 67 76
5. S. Asadi, and T.C. Theoharides Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin J. Neuroinflammation 4 2012 9:85
6. 2 and thimerosal-induced VEGF release from human mast cells Int. J. Immunopathol. Pharmacol. 23 4 2010 1015 1020
7. A.M. Avunduk, M.C. Avunduk, Z. KapIcIoglu, N. Akyol, and L. TavlI Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis Ophthalmology 107 2000 1333 1337
8. I. Bachelet, A. Munitz, and F. Levi-Schaffer Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a J. All. Clin. Immunol. 117 6 2006 1314 1320
9. J.W. Barlow, A.P. McHugh, O. Woods, and J.J. Walsh Synthesis of novel mast cell-stabilising and anti-allergic 1,2,3,4-tetrahydro-1-naphthalenols and related compounds Eur. J. Med. Chem. 46 2011 1545 1554
10. J.W. Barlow, and J.J. Walsh Synthesis and evaluation of 4-amino-3,4-dihydro-2H-naphthalen-1-one derivatives as mast cell stabilising and anti-inflammatory compounds Eur. J. Med. Chem. 43 2008 2891 2900
11. J.W. Barlow, and J.J. Walsh Synthesis and evaluation of dimeric 1,2,3,4-tetrahydro-naphthalenylamine and indan-1-ylamine derivatives with mast cell-stabilising and anti-allergic activity Eur. J. Med. Chem. 45 2010 25 37
12. J.W. Barlow, T. Zhang, O. Woods, A.J. Byrne, and J.J. Walsh Novel mast cell-stabilising amine derivatives of 3,4 dihydronaphthalen-1(2H)-one and 6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one Med. Chem. (Shariqah (United Arab Emirates)) 7 2011 213 223
13. M.A. Beaven, and R.A. Baumgartner Downstream signals initiated in mast cells by Fc epsilon RI and other receptors Curr. Opin. Immunol. 8 6 1996 766 772
14. P.P. Belliveau Omalizumab: a monoclonal anti-IgE antibody MedGenMed 7 1 2005 27
15. S.C. Bischoff, and G. Sellge Mast cell hyperplasia: role of cytokines Int. Arch. Allergy Immunol. 127 2002 118 122
16. S. Braselmann, V. Taylor, H. Zhao, S. Wang, C. Sylvain, M. Baluom, K. Qu, E. Herlaar, A. Lau, C. Young, B.R. Wong, S. Lovell, T. Sun, G. Park, A. Argade, S. Jurcevic, P. Pine, R. Singh, E.B. Grossbard, D.G. Payan, and E.S. Masuda R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation J. Pharmacol. Exp. Ther. 319 3 2006 998 1008
17. R.N. Brogden, and E.M. Sorkin Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma Drugs 45 5 1993 693 715
18. A.J. Byrne, J.W. Barlow, and J.J. Walsh Synthesis and pharmacological evaluation of the individual stereoisomers of 3-[methyl(1,2,3,4-tetrahydro-2-naphthalenyl)amino]-1-indanone, a potent mast cell stabilising agent Bioorg. Med. Chem. Lett. 15 2011 1191 1194
19. S. Cemerski, S.Y. Chu, G.L. Moore, U.S. Muchhal, J.R. Desjarlais, and D.E. Szymkowski Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb Immunol. Lett. 143 1 2012 34 43
20. H.-S. Chae, S.-R. Oh, H.-K. Lee, S.-H. Joo, and Y.-W. Chin Mangosteen xanthones, α-and γ-mangostins, inhibit allergic mediators in bone marrow-derived mast cell. Food Chem. 134 2012 397 400
21. T.K. Chan, D.S. Ng, C. Cheng, S.P. Guan, H.M. Koh, and W.S. Wong Anti-allergic actions of rottlerin from Mallotus philippinensis in experimental mast cell-mediated anaphylactic models Phytomed 20 10 2013 853 860
22. N. Chand, W. Diamantis, J. Pillar, and R.D. Sofia Inhibition of allergic and non-allergic histamine secretion from rat peritoneal mast cells by calcium antagonists Br. J. Pharmacol. 83 4 1984 899 902
23. B.Y. Chang, M.M. Huang, M. Francesco, J. Chen, J. Sokolove, P. Magadala, W.H. Robinson, and J.J. Buggy The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells Arthritis Res. Ther. 13 2011 R115
24. C. Cheng, D.S. Ng, T.K. Chan, S.P. Guan, W.E. Ho, A.H. Koh, J.S. Bian, H.Y. Lau, and W.S. Wong Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models Allergy 68 2013 195 203
25. Y.H. Choi, and G.H. Yan Ellagic acid attenuates immunoglobulin E-mediated allergic response in mast cells Biol. Pharm. Bull. 32 2009 1118 1121
26. Y.H. Choi, and G.H. Yan Silibinin attenuates mast cell-mediated anaphylaxis-like reactions Biol. Pharm. Bull. 32 2009 868 875
27. M.K. Church, and C.F. Gradidge The activity of sodium cromoglycate analogues in human lung in vitro: a comparison with rat passive cutaneous anaphylaxis and clinical efficacy Br. J. Pharmacol. 70 1980 307 311
28. P.S. Costello, M. Turner, A.E. Walters, C.N. Cunningham, P.H. Bauer, J. Downward, and V.L. Tybulewicz Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells Oncogene 13 1996 2595 2605
29. O.J. D'Cruz, and F.M. Uckun Targeting mast cells in endometriosis with janus kinase 3 inhibitor, JANEX-1 Am. J. Reprod. Immunol. 58 2007 75 97
30. M. de Souza Santos, M.P. Freire de Morais Del Lama, L.A. Deliberto, F. da Silva Emery, M. Tallarico Pupo, and R.M. Zumstein Georgetto Naal In situ screening of 3-arylcoumarin derivatives reveals new inhibitors of mast cell degranulation Arch. Pharm. Res. 36 2013 731 738
31. S. Dodig, D. Richter, I. Cepelak, and B. Benko Anti-IgE therapy with omalizumab in asthma and allergic rhinitis Acta Pharm. 55 2 2005 123 138
32. R.P. Eady, B. Greenwood, D.M. Jackson, T.S.C. Orr, and E. Wells The effect of nedocromil sodium and sodium cromoglycate on antigen-induced bronchoconstriction in the Ascaris-sensitive monkey Br. J. Pharmacol. 85 1985 323 325
33. A.M. Edwards, and A.A. Norris Cromoglycate and asthma Lancet 343 1994 426
34. P. Ehrlich Beiträge zur Theorie und Praxis der histologischen Färbung 1878 University of Leipzig Leipzig
35. D.S. El-Agamy Anti-allergic effects of nilotinib on mast cell-mediated anaphylaxis like reactions Eur. J. Pharmacol. 680 2012 115 121
36. A. Erdei, G.K. Toth, M. Andrasfalvy, J. Matko, L. Bene, Z. Bajtay, A. Ischenko, X. Rong, and I. Pecht Inhibition of IgE-mediated triggering of mast cells by complement-derived peptides interacting with the Fc epsilon RI Immunol. Lett. 68 1999 79 82
37. N. Erin, Y. Ersoy, F. Ercan, A. Akici, and S. Oktay NK-1 antagonist CP99994 inhibits stress-induced mast cell degranulation in rats J. Clin. Exp. Dermatol. 29 2004 644 648
38. I. Finegold, D.B. Granet, P.A. D'Arienzo, and A.B. Epstein Efficacy and response with olopatadine versus epinastine in ocular allergic symptoms: a post hoc analysis of data from a conjunctival allergen challenge study Clin. Ther. 28 2006 1630 1638
39. D.F. Finn, and J.J. Walsh Twenty-first century mast cell stabilizers Br. J. Pharmacol. 170 1 2013 23 37
40. 2+ level Eur. J. Pharmacol. 602 2009 432 438
41. S.J. Galli, M. Maurer, and C.S. Lantz Mast cells as sentinels of innate immunity Curr. Opin. Immunol. 11 1999 53 59
42. B.F. Gibbs, W. Schmutzler, I.B. Vollrath, P. Brosthardt, U. Braam, H.H. Wolff, and G. Zwadlo-Klarwasser Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells Inflamm. Res. 48 1999 86 93
43. S.M. Grant, K.L. Goa, A. Fitton, and E.M. Sorkin Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in asthma and allergic disorders Drugs 40 3 1990 412 448
44. S.J. Han, E.A. Bae, H.T. Trinh, J.H. Yang, U.J. Youn, K.H. Bae, and D.H. Kim Magnolol and honokiol: inhibitors against mouse passive cutaneous anaphylaxis reaction and scratching behaviors Biol. Pharm. Bull. 30 2007 2201 2203
45. S.Y. Han, J.Y. Bae, S.H. Park, Y.H. Kim, J.H. Park, and Y.H. Kang Resveratrol inhibits IgE-mediated basophilic mast cell degranulation and passive cutaneous anaphylaxis in mice J. Nutr. 143 2013 632 639
46. C.A. Harrison, R. Bastan, M.J. Peirce, M.R. Munday, and P.T. Peachell Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506 Br. J. Pharmacol. 150 2007 509 518
47. H. Hisamichi, R. Naito, A. Toyoshima, N. Kawano, A. Ichikawa, A. Orita, M. Orita, N. Hamada, M. Takeuchi, M. Ohta, and S.-i Tsukamoto Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivatives Bioorg. Med. Chem. 13 2005 4936 4951
48. K. Hitomi, S. Tahara-Hanaoka, S. Someya, A. Fujiki, H. Tada, T. Sugiyama, S. Shibayama, K. Shibuya, and A. Shibuya An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions Nat. Immunol. 11 7 2010 601 607
49. W.E. Ho, H.Y. Peh, T.K. Chan, and W.S.F. Wong Artemisinins: pharmacological actions beyond anti-malarial Pharmacol. Ther. 142 2014 126 139
50. F. Huang, K. Yamaki, X. Tong, L. Fu, R. Zhang, Y. Cai, R. Yanagisawa, K.-i Inoue, H. Takano, and S. Yoshino Inhibition of the antigen-induced activation of RBL-2H3 cells by sinomenine Int. Immunopharmacol. 8 2008 502 507
51. Y. Ikarashi, M. Yuzurihara, I. Sakakibara, Y. Nakai, N. Hattori, and Y. Maruyama Effects of the extract of the bark of Magnolia obovata and its biphenolic constituents magnolol and honokiol on histamine release from peritoneal mast cells in rats Planta Med. 67 2001 709 713
52. T. Inoue, Y. Suzuki, and C. Ra Epigallocatechin-3-gallate inhibits mast cell degranulation, leukotriene C4 secretion, and calcium influx via mitochondrial calcium dysfunction Free Radic. Biol. Med. 49 2010 632 640
53. T. Itoh, K. Ohguchi, M. Iinuma, Y. Nozawa, and Y. Akao Inhibitory effect of xanthones isolated from the pericarp of Garcinia mangostana L. on rat basophilic leukemia RBL-2H3 cell degranulation Bioorg. Med. Chem. 16 2008 4500 4508
54. K. Izawa, Y. Yamanishi, A. Maehara, M. Takahashi, M. Isobe, S. Ito, A. Kaitani, T. Matsukawa, T. Matsuoka, F. Nakahara, T. Oki, H. Kiyonari, T. Abe, K. Okumura, T. Kitamura, and J. Kitaura The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide Immunity 37 5 2012 827 839
55. B.M. Jensen, M.A. Beaven, S. Iwaki, D.D. Metcalfe, and A.M. Gilfillan Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation J. Pharmacol. Exp. Ther. 324 2008 128 138
56. H.G. Johnson, and A.Q. Sheridan The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma Agents Actions 18 1986 301 305
57. O.H. Kang, J.H. Lee, and D.Y. Kwon Apigenin inhibits release of inflammatory mediators by blocking the NF-κB activation pathways in the HMC-1 cells Immunopharmacol. Immunotoxicol. 33 2011 473 479
58. K. Karaman, L. Znaor, S. Cvitanović, S. Marković, S. Miljak, and A. Siničić Treatment of allergic conjunctivitis with olopatidine Acta Clin. Croat 47 Suppl 1 2008 21 25
59. T. Kawakami, N. Inagaki, M. Takei, H. Fukamachi, K.M. Coggeshall, K. Ishizaka, and T. Ishizaka Tyrosine phosphorylation is required for mast cell activation by Fc epsilon RI cross-linking J. Immunol. 148 1992 3513 3519
60. D. Kempuraj, M.L. Castellani, C. Petrarca, S. Frydas, P. Conti, T.C. Theoharides, and J. Vecchiet Inhibitory effect of quercetin on tryptase and interleukin-6 release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line Clin. Exp. Med. 6 2006 150 156
61. D. Kempuraj, M. Huang, K. Kandere-Grzybowska, S. Basu, W. Boucher, R. Letourneau, A. Athanassiou, and T.C. Theoharides Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells Int. Arch. All. Immunol. 132 2003 231 239
62. D. Kempuraj, M. Huang, K. Kandere, W. Boucher, R. Letourneau, S. Jeudy, K. Fitzgerald, K. Spear, A. Athanasiou, and T.C. Theoharides Azelastine is more potent than olopatadine in inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells Ann. Allergy Asthma Immunol. 88 5 2002 501 506
63. D. Kempuraj, B. Madhappan, S. Christodoulou, W. Boucher, J. Cao, N. Papadopoulou, C.L. Cetrulo, and T.C. Theoharides Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells Br. J. Pharmacol. 145 2005 934 944
64. S. Kiefer, A.C. Mertz, A. Koryakina, M. Hamburger, and P. Kuenzi (E,Z)-3-(3′,5′-Dimethoxy-4′-hydroxy-benzylidene)-2-indolinone blocks mast cell degranulation Eur. J. Pharm. Sci. 40 2010 143 147
65. K. Kim do, J.H. Lee, J.W. Kim, H.S. Kim, A.R. Kim, B.K. Kim, K.Y. Yi, H.J. Park, D.K. Park, and W.S. Choi A novel imidazo[1,5-b]isoquinolinone derivative, U63A05, inhibits Syk activation in mast cells to suppress IgE-mediated anaphylaxis in mice J. Pharmacol. Sci. 115 2011 500 508
66. D.Y. Kim, T.B. Kang, D.W. Shim, X. Sun, J.W. Han, Y.E. Ji, T.J. Kim, S. Koppula, and K.H. Lee Emodin attenuates A23187-induced mast cell degranulation and tumor necrosis factor-α secretion through protein kinase C and IκB kinase 2 signaling Eur. J. Pharmacol. 15 723 2014 501 506
67. H.P. Kim, H. Park, K.H. Son, H.W. Chang, and S.S. Kang Biochemical pharmacology of biflavonoids: implications for anti-inflammatory action Arch. Pharm. Res. 31 2008 265 273
68. J.W. Kim, J.H. Lee, B.Y. Hwang, S.H. Mun, N.Y. Ko, Kim do, K. Kim, B. Kim, H.S. Kim, and Y.M. Choi, W.S. Morin inhibits Fyn kinase in mast cells and IgE-mediated type I hypersensitivity response in vivo Biochem. Pharmacol. 77 2009 1506 1512
69. M. Kim, S.,J. Lim, S. Oidovsambuu, and C.W. Nho Gnetin H isolated from Paeonia anomala inhibits FcϵRI-mediated mast cell signaling and degranulation J. Ethnopharm. 154 2014 798 806
70. N.H. Kim, H.J. Jeong, and H.M. Kim Theanine is a candidate amino acid for pharmacological stabilization of mast cells Amino acids 42 2012 1609 1618
71. S.-H. Kim, S. Lee, I.K. Kim, T.K. Kwon, J.-Y. Moon, W.-H. Park, and T.-Y. Shin Suppression of mast cell-mediated allergic reaction by Amomum xanthiodes Food Chem. Toxicol. 45 2007 2138 2144
72. M. Kimata, N. Inagaki, and H. Nagai Effects of luteolin and other flavonoids on IgE-mediated allergic reactions Planta Med. 66 2000 25 29
73. M. Kimata, M. Shichijo, T. Miura, I. Serizawa, N. Inagaki, and H. Nagai Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells Clin. Exp. Allergy 30 2000 501 508
74. T. Kiwamoto, N. Kawasaki, J.C. Paulson, and B.S. Bochner Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions Pharmacol. Ther. 135 3 2012 327 336
75. M. Kneidinger, U. Schmidt, U. Rix, K.V. Gleixner, A. Vales, C. Baumgartner, C. Lupinek, M. Weghofer, K.L. Bennett, H. Herrmann, A. Schebesta, W.R. Thomas, S. Vrtala, R. Valenta, F.Y. Lee, W. Ellmeier, G. Superti-Furga, and P. Valent The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils Blood 111 6 2008 3097 3107
76. M.T. Krauth, Y. Majlesi, K. Sonneck, P. Samorapoompichit, M. Ghannadan, A.W. Hauswirth, M. Baghestanian, G.H. Schernthaner, C. Worda, M.R. Muller, W.R. Sperr, and P. Valent Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells Allergy 61 2006 281 288
77. H.Y. Lau, and M.F. Kam Inhibition of mast cell histamine release by specific phosphodiesterase inhibitors Inflamm. Res. 54 Suppl 1 2005 S05 S06
78. J.H. Lee, J.W. Kim, N.Y. Ko, S.H. Mun, E. Her, B.K. Kim, J.W. Han, H.Y. Lee, M.A. Beaven, Y.M. Kim, and W.S. Choi Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk J. All. Clin. Immunol. 121 2008 1225 1231
79. K.S. Lee, H.K. Lee, J.S. Hayflick, Y.C. Lee, and K.D. Puri Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model FASEB J. 20 3 2006 455 465
80. T. Lee, S. Lee, K. Ho Kim, K.B. Oh, J. Shin, and W. Mar Effects of magnolialide isolated from the leaves of Laurus nobilis L. (Lauraceae) on immunoglobulin E-mediated type I hypersensitivity in vitro. J. Ethnopharm. 149 2 2013 550 556
81. Y.S. Lee, S. Hur, and T.Y. Kim Homoisoflavanone prevents mast cell activation and allergic responses by inhibition of Syk signaling pathway Allergy 69 4 2014 453 462
82. K.B.P. Leung, K.C. Flint, J. Brostoff, B.N. Hudspith, N. Johnson, H.Y.A. Lau, W.L. Liu, and F.L. Pearce Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells Thorax 43 1988 756 761
83. G.Z. Li, O.H. Chai, and C.H. Song Inhibitory effects of epigallocatechin gallate on compound 48/80-induced mast cell activation and passive cutaneous anaphylaxis Exp. Mol. Med. 37 2005 290 296
84. M. Li, P. Luraghi, A. Amour, X.-D. Qian, P.S. Carter, C.J. Clark, A. Deakin, J. Denyer, C.I. Hobbs, M. Surby, V.K. Patel, and E.M. Schaefer Kinetic assay for characterization of spleen tyrosine kinase activity and inhibition with recombinant kinase and crude cell lysates Anal. Biochem. 384 2009 56 67
85. W. Linwong, N. Hirasawa, S. Aoyama, H. Hamada, T. Saito, and K. Ohuchi Inhibition of the antigen-induced activation of rodent mast cells by putative Janus kinase 3 inhibitors WHI-P131 and WHI-P154 in a Janus kinase 3-independent manner Br. J. Pharmacol. 145 2005 818 828
86. R.E. Louis, and M.F. Radermecker Substance P-induced histamine release from human basophils, skin and lung fragments: effect of nedocromil sodium and theophylline Int. Arch. All. Appl. Immunol. 92 1990 329 333
87. D.C. Machado, D. Horton, R. Harrop, P.T. Peachell, and B.A. Helm Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen-specific IgE Eur. J. Immunol. 26 1996 2972 2980
88. A.,E. MacKenzie, G. Caltabiano, T.C. Kent, L. Jenkins, J.E. McCallum, B.D. Hudson, S.A. Nicklin, L. Fawcett, R. Markwick, S.J. Charlton, and G. Milligan The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35 Mol. Pharmacol. 85 2014 91 104
89. R. Malaviya, D. Zhu, I. Dibirdik, and F.M. Uckun Targeting Janus kinase 3 in mast cells prevents immediate hypersensitivity reactions and anaphylaxis J. Biol. Chem. 274 1999 27028 27038
90. E.S. Masuda, and J. Schmitz Syk inhibitors as treatment for allergic rhinitis Pulm. Pharmacol. Ther. 21 2008 461 467
91. H. Matsuda, H. Shimoda, and M. Yoshikawa Structure-requirements of isocoumarins, phthalides, and stilbenes from Hydrangeae Dulcis Folium for inhibitory activity on histamine release from rat peritoneal mast cells Bioorg. Med. Chem. 7 1999 1445 1450
92. D. Maurer, E. Fiebiger, B. Reininger, B. Wolff-Winiski, M.H. Jouvin, O. Kilgus, J.P. Kinet, and G. Stingl Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals J. Exp. Med. 179 1994 745 750
93. E.O. Meltzer, G.W. Bensch, and W.W. Storms New intranasal formulations for the treatment of allergic rhinitis Allergy Asthma Proc. 35 2014 S11 S19
94. A.L. Miller, C. Zhang, K.M. Shokat, and C.A. Lowell Generation of a novel system for studying spleen tyrosine kinase function in macrophages and B cells J. Immunol. 182 2009 988 998
95. N. Miyata, Y. Gon, S. Nunomura, D. Endo, K. Yamashita, K. Matsumoto, S. Hashimoto, and C. Ra Inhibitory effects of parthenolide on antigen-induced microtubule formation and degranulation in mast cells Int. Immunopharmacol. 8 2008 874 880
96. K. Moriya, J. Rivera, S. Odom, Y. Sakuma, K. Muramato, T. Yoshiuchi, M. Miyamoto, and K. Yamada ER-27319, an acridone-related compound, inhibits release of antigen-induced allergic mediators from mast cells by selective inhibition of fcepsilon receptor I-mediated activation of Syk Proc. Natl. Acad. Sci. USA 94 1997 12539 12544
97. J.J. Murphy, S. Heptinstall, and J.R. Mitchell Randomised double-blind placebo-controlled trial of feverfew in migraine prevention Lancet 2 1988 189 192
98. A.J. Nauta, F. Engels, L.M. Knippels, J. Garssen, F.P. Nijkamp, and F.A. Redegeld Mechanisms of allergy and asthma Eur. J. Pharmacol. 585 2008 354 360
99. F. Nimmerjahn, and J.V. Ravetch Fcgamma receptors as regulators of immune responses Nat. Rev. Immunol. 8 1 2008 34 47
100. A.E. Nugroho, Z. Ikawati, Sardjiman, and K. Maeyama Effects of benzylidenecyclopentanone analogues of curcumin on histamine release from mast cells Biol. Pharm. Bull. 32 2009 842 849
101. 3 receptor, attenuates the increase in cytosolic calcium level and degranulation that is induced by antigen in RBL-2H3 mast cells Br. J. Pharmacol. 135 2002 1959 1966
102. K. Okkenhaug Two birds with one stone: dual p110δ and p110γ inhibition Chem. Biol. 20 11 2013 1309 1310
103. T.S.C. Orr, D.E. Hall, J.M. Gwilliam, and J.S.G. Cox The effect of cromolyn sodium on the release of histamine and degranulation of rat mast cells induced by Compound 48/80 Life Sci. 10 1 1971 805 812
104. F. Özturk, M. Guler, S. Sami-Ilker, and G. Sobaci Efficacy of topical lodoxamide vs sodium cromoglycate and dexamethasone in rabbits with passive allergic conjunctivitis Ann. Ophthalmol. 34 2002 100 103
105. C.E. Owen Immunoglobulin E: role in asthma and allergic disease: Lessons from the clinic Pharmacol. Ther. 113 2007 121 133
106. H.H. Park, S. Lee, H.Y. Son, S.B. Park, M.S. Kim, E.J. Choi, T.S. Singh, J.H. Ha, M.G. Lee, J.E. Kim, M.C. Hyun, T.K. Kwon, Y.H. Kim, and S.H. Kim Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells Arch. Pharm. Res. 31 2008 1303 1311
107. P. Patel, P.S. Roland, B.F. Marple, P.J. Benninger, H. Margalias, M. Brubaker, S.F. Beezley, M. Drake, S.L. Potts, and G.M. Wall An assessment of the onset and duration of action of olopatadine nasal spray Otolaryngol. Head Neck Surg. 137 2007 918 924
108. A.B. Penissi, M.E. Vera, M.L. Mariani, M.I. Rudolph, J.P. Cenal, J.C. de Rosas, T.H. Fogal, C.E. Tonn, L.S. Favier, O.S. Giordano, and R.S. Piezzi Novel anti-ulcer alpha,beta-unsaturated lactones inhibit compound 48/80-induced mast cell degranulation Eur. J. Pharmacol. 612 2009 122 130
109. F.A. Persia, M.L. Mariani, T.H. Fogal, and A.B. Penissi Hydroxytyrosol and oleuropein of olive oil inhibit mast cell degranulation induced by immune and non-immune pathways Phytomed 21 2014 1400 1405
110. H. Peterfy, G. Toth, I. Pecht, and A. Erdei C3a-derived peptide binds to the type I FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells Int. Immunol. 20 2008 1239 1245
111. P. Pipkorn, C. Costantini, C. Reynolds, M. Wall, M. Drake, A. Sanico, D. Proud, and A. Togias The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation Ann. Allergy Asthma Immunol. 101 2008 82 89
112. I. Puxeddu, D. Ribatti, E. Crivellato, and F. Levi-Schaffer Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases J. All. Clin. Immunol. 116 2005 531 536
113. C.V. Rao Acquired immunity or adaptive immune response, An Introduction to Immunology 2002 Alpha Science International Ltd. Oxford, United Kingdom 40 42
114. C.V. Rao Antibodies (Immunoglobulins), An Introduction to immunology 2002 Alpha Science Inernational Ltd. Oxford, United Kingdom 115 116
115. C.K. Rhee, J.Y. Kang, C.K. Park, S.Y. Lee, S.S. Kwon, Y.K. Kim, and H.K. Yoon Effect of nilotinib on airway remodeling in a murine model of chronic asthma Exp. Lung Res. 40 2014 199 210
116. M. Robbie-Ryan, and M.A. Brown The role of mast cells in allergy and autoimmunity Curr. Opin. Immunol. 14 2002 728 733
117. A.B. Rossi, E. Herlaar, S. Braselmann, S. Huynh, V. Taylor, R. Frances, S.D. Issakani, A. Argade, R. Singh, D.G. Payan, and E.S. Masuda Identification of the Syk kinase inhibitor R112 by a human mast cell screen J. All. Clin. Immunol. 118 2006 749 755
118. G.U. Ruster, B. Hoffmann, and M. Hamburger Inhibitory activity of indolin-2-one derivatives on compound 48/80-induced histamine release from mast cells Die Pharm. 59 2004 236 237
119. C. Saltoun, and P.C. Avila Advances in upper airway diseases and allergen immunotherapy in 2007 J. All. Clin. Immunol. 122 2008 481 487
120. A.M. Sanico, C. Bloom, C.J. Reynolds, G.M. Wall, M.M. Drake, S.F. Beezley, and A. Togias Olopatadine suppresses nasal allergic reactions J. All. Clin. Immunol. 113 2004 S341 S404
121. G. Schwarzer, D. Bassler, A. Mitra, F.M. Ducharme, and J. Forster Ketotifen alone or as additional medication for long-term control of asthma and wheeze in children Cochrane Database Syst. Rev. 1 2004 CD001384
122. T. Sengoku, S. Kishi, S. Sakuma, Y. Ohkubo, and T. Goto FK506 inhibition of histamine release and cytokine production by mast cells and basophils Int. J. Immunopharmacol. 22 1999 189 201
123. H. Sheridan, S. Butterly, J.J. Walsh, C. Cogan, M. Jordan, O. Nolan, and N. Frankish Synthesis and pharmacological activity of aminoindanone dimers and related compounds Bioorg. Med. Chem. 16 2008 248 254
124. H. Sheridan, N. Frankish, and R. Farrell Synthesis and antispasmodic activity of analogues of natural pterosins Eur. J. Med. Chem. 34 1999 953 966
125. H. Sheridan, J.J. Walsh, C. Cogan, M. Jordan, T. McCabe, E. Passante, and N.H. Frankish Diastereoisomers of 2-benzyl-2, 3-dihydro-2-(1H-inden-2-yl)-1H-inden-1-ol: potential anti-inflammatory agents Bioorg. Med. Chem. Lett. 19 2009 5927 5930
126. H. Sheridan, J.J. Walsh, M. Jordan, C. Cogan, and N. Frankish A series of 1, 2-coupled indane dimers with mast cell stabilisation and smooth muscle relaxation properties Eur. J. Med. Chem. 44 2009 5018 5022
127. G.R. Stenton, and H.Y. Lau Inhibition of rat peritoneal mast cell exocytosis by frusemide: a study with different secretagogues Inflamm. Res. 45 1996 508 512
128. G.R.1 Stenton, L.F. Mackenzie, P. Tam, J.L. Cross, C. Harwig, J. Raymond, J. Toews, D. Chernoff, T. MacRury, and C. Szabo Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 2. Efficacy studies in allergic and pulmonary inflammation models in vivo Br. J. Pharmacol. 168 6 2013 1519 1529
129. R.T. Strait, S.C. Morris, M. Yang, X.-W. Qu, and F.D. Finkelman Pathways of anaphylaxis in the mouse J. All. Clin. Immunol. 109 2002 658 668
130. M. Sundström, J. Alfredsson, N. Olsson, and G. Nilsson Stem cell factor-induced migration of mast cells requires p38 mitogen-activated protein kinase activity Exp. Cell Res. 267 2001 144 151
131. B.J. Sutton, R.L. Beavil, and A.J. Beavil Inhibition of IgE-receptor interactions Br. Med. Bull. 56 2000 1004 1018
132. H. Suzuki, M. Takei, M. Yanagida, T. Nakahata, T. Kawakami, and H. Fukamachi Early and late events in Fc epsilon RI signal transduction in human cultured mast cells J. Immunol. 159 1997 5881 5888
133. R. Suzuki, T. Furuno, D.M. McKay, D. Wolvers, R. Teshima, M. Nakanishi, and J. Bienenstock Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P J Immunol. 163 1999 2410 2415
134. T. Tamura, and M. Komai Effect of olopatadine hydrochloride, an anti-histamine drug, on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats Int. Immunopharmacol. 8 2008 916 921
135. T.C. Theoharides, and D.E. Cochrane Critical role of mast cells in inflammatory diseases and the effect of acute stress J. Neuroimmunol. 146 2004 1 12
136. T.C. Theoharides, and P. Conti Mast cells: the Jekyll and Hyde of tumor growth Trends Immunol. 25 5 2004 235 241
137. T.C. Theoharides, J.M. Donelan, N. Papadopoulou, J. Cao, D. Kempuraj, and P. Conti Mast cells as targets of corticotrophin-releasing factor and related peptides Trends Pharmacol. Sci. 25 2004 563 568
138. G.L. Torkildsen, G.W. Ousler 3rd, and P. Gomes Ocular comfort and drying effects of three topical antihistamine/mast cell stabilizers in adults with allergic conjunctivitis: a randomized, double-masked crossover study Clin. Ther. 30 2008 1264 1271
139. Y. Tsujimura, K. Obata, K. Mukai, H. Shindou, M. Yoshida, H. Nishikado, Y. Kawano, Y. Minegishi, T. Shimizu, and H. Karasuyama Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis Immunity 28 2008 581 589
140. H. Turner, and J.P. Kinet Signalling through the high-affinity IgE receptor Fc epsilonRI Nature 402 6760 Suppl 1999 B24 B30
141. W.A. Velema, M. van der Toorn, W. Szymanski, and B.L. Feringa Design, synthesis, and inhibitory activity of potent, photoswitchable mast cell activation inhibitors J. Med. Chem. 56 11 2013 4456 4464
142. J. Wedemeyer, M. Tsai, and S.J. Galli Roles of mast cells and basophils in innate and acquired immunity Curr. Opin. Immunol. 12 2000 624 631
143. Z. Weng, B. Zhang, S. Asadi, N. Sismanopoulos, A. Butcher, X. Fu, A. Katsarou-Katsari, C. Antoniou, and T.C. Theoharides Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans PLoS One 7 3 2012 e33805
144. M.C. Weston, N. Anderson, and P.T. Peachell Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function Br. J. Pharmacol. 121 1997 287 295
145. K. Yamaki, and S. Yoshino Tyrosine kinase inhibitor sunitinib relieves systemic and oral antigen-induced anaphylaxes in mice Allergy 67 1 2012 114 122
146. N. Yamamoto, K. Takeshita, M. Shichijo, T. Kokubo, M. Sato, K. Nakashima, M. Ishimori, H. Nagai, Y.F. Li, T. Yura, and K.B. Bacon The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents J. Pharmacol. Exp. Ther. 306 2003 1174 1181
147. Y.H. Yang, J.Y.L. Lu, X.S. Wu, S. Summer, J. Whoriskey, C. Saris, and J.D. Reagan G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium Pharmacology 86 2010 1 5
148. J.M. Yanni, D.J. Stephens, S.T. Miller, L.K. Weimer, G. Graff, D. Parnell, L.S. Lang, J.M. Spellman, M.T. Brady, and D.A. Gamache The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent J. Ocul. Pharmacol. Ther. 12 1996 389 400
149. S. Yazid, A. Sinniah, E. Solito, V. Calder, and R.J. Flower Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1 PLoS One 8 2013 e58963
150. 2+ mobilization. Toxicol. Appl. Pharmacol. 264 2012 462 469